Sort
50,496 grants matching “lung cancer”
Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States
$692,822Xuehong Zhang · Yale University · U01 · FY2024 · CA
Practical high resolution microscopy of un-cut, un-embedded lung biopsies
$692,728Michael John Levene · Applikate Technologies, Inc. · R44 · FY2018 · CA
Value of Information Methods for NHLBI Trials
$692,668Anirban Basu · University Of Washington · R01 · FY2017 · HL
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
$692,607David A Williams · Boston Children'S Hospital · UH3 · FY2024 · HL
A non-invasive blood test for multi-cancer detection and determination of tissue of origin preceding overt cancer diagnosis
$692,491Marc Bissonnette · University Of Chicago · U01 · FY2025 · CA
Molecular Phenotypes for Lung Diseases
$692,485David Brian Corry · Baylor College Of Medicine · R01 · FY2009 · HL
Evaluation of genetic, clinical, and environmental risk factors to establish effective screening strategies for second primary lung cancer
$692,450Summer S Han · Stanford University · R37 · FY2018 · CA
Antifibrotic Therapy to Improve Immune reconstitution in HIV
$692,430Timothy W Schacker · University Of Minnesota · R01 · FY2012 · AI
Multi-cellular interactions defining the human brain metastatic niche
$692,427Benjamin Izar · Columbia University Health Sciences · R01 · FY2025 · CA
Health Disparities and CVD: Admixture Mapping in the Jackson Heart Study
$692,378James Graham Wilson · University Of Mississippi Med Ctr · R01 · FY2008 · HL
Telehealth based exercise intervention to improve functional capacity in survivors of childhood cancer with significantly limited exercise tolerance
$692,366Kirsten Kimberlie Ness · St. Jude Children'S Research Hospital · U01 · FY2024 · CA
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
$692,343David A Williams · Boston Children'S Hospital · UG3 · FY2022 · HL
Leadership, Planning, and Evaluation
$692,337Stanton L Gerson · Case Western Reserve University · P30 · FY2021 · CA
Intensive tailored exercise training with NAD+ precursor supplementation to improve muscle mass and fitness in adolescent and young adult survivors of hematopoietic stem cell transplantation
$692,336Sogol Mostoufi-Moab · Children'S Hosp Of Philadelphia · R01 · FY2025 · CA
Incorporating Biomarkers to Improve Lung Cancer Risk Prediction
$692,318Ziding Feng · University Of Tx Md Anderson Can Ctr · U01 · FY2016 · CA
Early Diagnosis of Pancreatic Cancer
$692,241Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2008 · CA
Molecular Phenotypes for Lung Diseases
$692,215David Brian Corry · Baylor College Of Medicine · R01 · FY2010 · HL
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
$692,001Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
$692,001Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Cancer Center Support Grant
$692,000Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · CA
Longitudinal Studies of HIV-Associated Lung Infections and Complications
$691,883Kristina Anne Crothers · University Of Washington · R01 · FY2011 · HL
Cincinnati Center for Excellence in Molecular Hematology
$691,861Yi Zheng · Cincinnati Childrens Hosp Med Ctr · P30 · FY2011 · DK
Cincinnati Center for Excellence in Molecular Hematology
$691,861Yi Zheng · Cincinnati Childrens Hosp Med Ctr · P30 · FY2014 · DK
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)
$691,805Debra L Friedman · Vanderbilt University Medical Center · R01 · FY2019 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial
$691,713Douglas Reding · Marshfield Clinic Research Foundation · N01 · FY2010 · CA